Title : The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo.

Pub. Date : 2010 Aug

PMID : 20225261






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colony-stimulating factor (M-CSF) receptor c-fms. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens